TNF and gastric cancer: Systemic lidocaine was also reported to improve postoperative recovery, alleviate inflammation and immunosuppression with a decrease in plasma TNF-α, and accelerate the return of bowel function in patients with gastric cancer undergoing laparoscopic radical gastrectomies [119].